RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Regen Med. 2009 Nov;4(6):911-8. doi: 10.2217/rme.09.60.
For the past decade, forays into stem cell research and regenerative medicine by institutes and companies based in the Asia-Pacific region have attracted global attention at levels unprecedented in the life sciences. The unique combination of economic pressures, competitiveness and opportunism, laissez-faire regulation, burgeoning investment in the life sciences and rapidly growing markets, coupled with its great diversity, have propelled the region to surge forward in some areas, but to stumble in others. This article provides a historical and scientific context to the state of stem cell research and clinical applications in the region, and highlights trends and new possibilities to watch for on the Asian horizon.
在过去的十年中，亚太地区的研究所和公司在干细胞研究和再生医学方面的探索引起了生命科学界前所未有的全球关注。经济压力、竞争和机会主义的独特结合、放任的监管、生命科学投资的蓬勃发展和市场的快速增长，再加上其巨大的多样性，推动该地区在一些领域取得了突飞猛进的发展，但在其他领域却步履蹒跚。本文为该地区的干细胞研究和临床应用状况提供了历史和科学背景，并强调了亚洲地平线上值得关注的趋势和新可能性。
